Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Tuula Kuukasjärvi, Ritva Karhu, Minna Tanner, +7

PubMed

Breast OncologyGeneticsPathologyHuman Breast CancerMammary Gland Development +16

Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients

J Isola, Tapio Visakorpi, K Holli, +1

JNCI Journal of the National Cancer Institute

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

Tapio Visakorpi, Olli Kallioniemi, A. Heikkinen, +2

JNCI Journal of the National Cancer Institute

Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

Minna M. Tanner, Mika Tirkkonen, Anne Kallioniemi, +9

PubMed

ChromatinCytogeneticsTumor HeterogeneityMedicinePathology +13

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.

K Holli, J Isola, Jack Cuzick

Journal of Clinical Oncology

Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.

Minna M. Tanner, Mika Tirkkonen, Anne Kallioniemi, +6

PubMed

Breast OncologyCancer PathologyChromosomal Region 20Q13PathologyPrognostic Implications +16

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

Irma Saarenmaa, Tiina Salminen, U. Geiger, +14

Breast Cancer Research and Treatment

Breast OncologyCancer DetectionBreast ImagingBreast CancerBiostatistics +2

Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.

Tapio Visakorpi, Olli Kallioniemi, T. Koivula, +2

PubMed

Androgen Receptor Gene Amplificationin a Recurrent Prostate Cancer afterMonotherapy with the NonsteroidalPotent Antiandrogen Casodex(Bicalutamide) with a SubsequentFavorable Response to MaximalAndrogen Blockade

Christian Palmberg, Pasi Koivisto, E. Hyylinen, +4

European Urology

A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy.

Angelo Di Leo, J Isola, Fanny Piette, +12

Cancer Research

Breast OncologyPathologyPredictive ValueTumor BiologyColor Fish Test +16